*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
The Competition and Markets Authority has unconditionally cleared Just Eat’s acquisition of Hungryhouse, saying the deal does not raise any competition concerns.
GlaxoSmithKline and Innoviva have been granted marketing authorisation by the European Commission for their Trelegy Ellipta once-daily single inhaler triple therapy for the treatment of adult patients with moderate to severe chronic obstructive pulmonary disease.
Prudential said on Thursday that life insurance new business profit rose 17% in the first nine months of the year, reflecting higher sales and more favourable economic conditions.
